Group 1: Company Developments - Banu International Holdings Limited submitted its listing application to the Hong Kong Stock Exchange, reporting revenues of 5.639 billion RMB in Q1 2024 and 7.087 billion RMB in Q1 2025, with adjusted net profits of 575 million RMB and 767 million RMB respectively [1] - Midea Group announced a share repurchase plan with a maximum amount of 10 billion RMB and a minimum of 5 billion RMB, aiming to repurchase up to 1 billion shares, which is approximately 1.30% of the total issued shares [6] - *ST Zhongdi plans to transfer its real estate development assets and liabilities to its controlling shareholder for 1 RMB, focusing on property services and asset management for strategic transformation [7] - Muyuan Foods announced that its application for H-share issuance has been accepted by the China Securities Regulatory Commission [8] - *ST Jiuyou's stock will be delisted, with the Shanghai Stock Exchange initiating the delisting process due to significant reporting violations, including a fine of 8.5 million RMB [10] - Weir Shares will change its name to Haowei Group, effective June 20, 2025 [11] - Three squirrels terminated the acquisition of Hunan Ailing Food Technology due to failure to reach agreement on core terms [12] - Bohai Automobile plans to acquire stakes in four automotive parts companies through a combination of share issuance and cash payments [13] - Zhujiang Beer elected a new chairman, Huang Wensheng, following the retirement of the previous chairman [14] Group 2: Industry Trends - The National Medical Products Administration announced measures to support innovative drug development, including a 30-day review process for clinical trial applications [3] - Guangdong Province aims to cultivate 3-5 leading enterprises in the nuclear medicine industry by 2030, enhancing innovation capabilities and establishing a competitive industry cluster [5] - The National Radio and Television Administration is implementing regulations to improve user experience in internet television services, addressing issues related to automatic renewal and user complaints [4] - Shanshui Technology plans to invest 6 billion RMB in a new chemical materials project, expected to generate an annual output value of 8 billion RMB upon completion [19]

Core Viewpoint - Yunlu Co., Ltd. (688190.SH) experienced a significant stock price increase of over 9% before announcing that its chairman and general manager, Li Xiaoyu, was detained by the Jilin Provincial Supervisory Committee [1][2]. Company Information - Yunlu Co., Ltd. was listed on the Sci-Tech Innovation Board in November 2021, with its actual controller being China Aviation Engine Group Co., Ltd. The company specializes in the research, production, and sales of amorphous alloys, nanocrystalline alloys, magnetic powders, and their products, which are primarily used in power distribution, photovoltaics, rail transportation, data centers, home appliances, and new energy vehicles [4]. Management Changes - Following the detention of Li Xiaoyu, Yunlu Co., Ltd. announced that during his inability to perform his duties, the vice chairman, Lei Rigan, would temporarily assume the role of chairman, while board member and deputy general manager, Pang Jing, would act as general manager and legal representative [3].

截至本公告披露日，公司尚未知悉上述事项的进展及结论，公司将持续关注 后续情况，并严格按照有关法律、法规和规范性文件的规定和要求，及时履行信 息披露义务。公司指定信息披露媒体为《中国证券报》《证券时报》《证券日报》 《上海证券报》和上海证券交易所网站（www.sse.com.cn），公司发布的信息均 以在上述媒体刊登的公告为准。敬请广大投资者理性投资，注意投资风险。 特此公告。 青岛云路先进材料技术股份有限公司董事会 本公司及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 青岛云路先进材料技术股份有限公司（以下简称"公司"）于近日得知，公 司董事长兼总经理李晓雨先生被吉林省吉林市监察委员会留置。该事项与本公司 无关，截至本公告出具日，公司未被要求协助调查，公司各项生产经营活动正常 进行，不会对公司的日常运营造成重大影响。 现经公司董事会过半数董事同意，在李晓雨先生不能履行董事长兼总经理职 责期间，暂由公司副董事长雷日赣代行董事长职责，由公司董事、副总经理庞靖 代行总经理及法定代表人职责。公司拥有完善的治理及内部控制机制，已对相关 事项做 ...

Core Viewpoint - The chairman and general manager of Yunlu Co., Ltd. has been detained by the Jilin Provincial Supervisory Committee, but this matter is unrelated to the company itself [1] Company Operations - The company has stated that it has not been requested to assist in any investigation and that its production and operational activities are proceeding normally [1] - During the period when the chairman is unable to perform his duties, the vice chairman will temporarily assume the role of chairman, while a board member and deputy general manager will take on the responsibilities of general manager and legal representative [1]

Group 1 - The core point of the article highlights the performance and holdings of the Jiao Yin State-Owned Enterprise Reform Flexible Allocation Mixed A Fund, which has a latest net value of 1.7797 yuan, showing a growth of 0.52% [1] - The fund's performance over the past month has yielded a return of 2.39%, ranking 580 out of 2329 in its category, while the three-month return is 4.99%, ranking 246 out of 2319 [1] - Since the beginning of the year, the fund has achieved a return of 3.88%, with a ranking of 540 out of 2306 in its category [1] Group 2 - The top ten stock holdings of the fund account for a total of 50.78%, with significant positions in companies such as SF Holding (9.90%), China Chemical (6.04%), and ShouLve Hotel (5.44%) [1] - As of March 31, 2025, the fund's total assets amount to 1.802 billion yuan, and it was established on June 10, 2015, with Shen Nan serving as the fund manager [1]

青岛云路先进材料技术股份有限公司 股东及董事减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东及董事持股的基本情况 证券代码：688190 证券简称：云路股份 公告编号：2025-030 一、减持主体减持前基本情况 1 | 持股数量 | 21,938,201股 | | --- | --- | | 持股比例 | 18.28% | | 当前持股股份来源 | IPO 前取得：21,938,201股 | 上述减持主体无一致行动人。 二、减持计划的实施结果 （一）股东及董事因以下事项披露减持计划实施结果： 本次减持计划实施前，股东郭克云持有青岛云路先进材料技术股份有限公司 （以下简称"公司"）股份 21,938,201 股，占公司总股本 18.28%，上述股份为 公司首次公开发行前取得的股份，已于 2022 年 11 月 28 日解除限售并上市流通。 减持计划的实施结果情况 公司于 2025 年 2 月 7 日披露了《青岛云路先进材料技术股份有限公司股东 及董事股份减持计划公告》（公告 ...

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]

证券代码：688190 证券简称：云路股份 公告编号：2025-029 青岛云路先进材料技术股份有限公司2024年年度权益分派 实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 是否涉及差异化分红送转：否 ? 每股分配比例 每股现金红利0.63元 ? 相关日期 股权登记日 除权（息）日 现金红利发放日 一、 通过分配方案的股东大会届次和日期 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 本次利润分配以方案实施前的公司总股本120,000,000股为基数，每股派发现 金红利0.63元（含税），共计派发现金红利75,600,000.00元。 三、 相关日期 股权登记日 除权（息）日 现金红利发放日 四、 分配实施办法 （1）除公司自行发放的对象外，公司其余股东的红利委托中国结算上海分公 司通过其资金清算系统向股权登记日上海证券交易所收市后登记在册并在上海证 券交易所各会员办理了指定交易的股 ...

证券代码：688190 证券简称：云路股份 公告编号：2025-029 青岛云路先进材料技术股份有限公司2024年年度权益分派 实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/5/30 | 2025/6/3 | 2025/6/3 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经青岛云路先进材料技术股份有限公司2025 年 4 月 18 日 的2024年年度股东大会审议通过。 二、 分配方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 是否涉及差异化分红送转：否 每股分配比例 每股现金红利0.63元 相关日期 三、 相关日期 | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | - ...

Group 1 - The core point of the article is the performance and holdings of the Jiao Yin State-Owned Enterprise Reform Flexible Allocation Mixed A Fund, which has a recent net value of 1.7633 yuan and a decline of 0.57% [1] - The fund's performance over the past month shows a return of 0.79%, ranking 89 out of 119 in its category; over the past six months, it has returned 3.61%, ranking 29 out of 117; and since the beginning of the year, it has returned 3.46%, ranking 24 out of 117 [1] - The fund's top ten stock holdings account for a total of 50.78%, with significant positions in companies such as SF Holding (9.90%), China Chemical (6.04%), and ShouLve Hotel (5.44%) [1] Group 2 - The Jiao Yin State-Owned Enterprise Reform Flexible Allocation Mixed A Fund was established on June 10, 2015, and as of March 31, 2025, it has a total scale of 1.802 billion yuan [1] - The fund manager, Shen Nan, has been in the role since the fund's inception and has a background in finance, holding a master's degree from Fudan University [2]